NO20031045L - Ny polymorf form av 17-<beta>-(N-tert.butylkarbamoyl)-4-aza-5- <alfa>-ANDROST-1-en-3-on og en fremgangsmåte for fremstilling av samme - Google Patents

Ny polymorf form av 17-<beta>-(N-tert.butylkarbamoyl)-4-aza-5- <alfa>-ANDROST-1-en-3-on og en fremgangsmåte for fremstilling av samme

Info

Publication number
NO20031045L
NO20031045L NO20031045A NO20031045A NO20031045L NO 20031045 L NO20031045 L NO 20031045L NO 20031045 A NO20031045 A NO 20031045A NO 20031045 A NO20031045 A NO 20031045A NO 20031045 L NO20031045 L NO 20031045L
Authority
NO
Norway
Prior art keywords
androst
butylcarbamoyl
alfa
aza
tert
Prior art date
Application number
NO20031045A
Other languages
English (en)
Other versions
NO20031045D0 (no
Inventor
Satyanarayana M Reddy
T S Rajan
Brahmeshwara M V N Rao
K Vyas
Vishnuvardhana S Reddy
Shashi K Rekha
Original Assignee
Reddys Lab Ltd Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr filed Critical Reddys Lab Ltd Dr
Publication of NO20031045D0 publication Critical patent/NO20031045D0/no
Publication of NO20031045L publication Critical patent/NO20031045L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20031045A 2000-09-07 2003-03-06 Ny polymorf form av 17-<beta>-(N-tert.butylkarbamoyl)-4-aza-5- <alfa>-ANDROST-1-en-3-on og en fremgangsmåte for fremstilling av samme NO20031045L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN737DE2000 2000-09-07
PCT/US2001/019546 WO2002020553A1 (en) 2000-09-07 2001-06-19 NOVEL POLYMORPHIC FORM OF 17-β-(N-TER.BUTYL CARBAMOYL)-4-AZA-5-α-ANDROST-1-EN-3-ONE AND A PROCESS FOR PREPARING IT

Publications (2)

Publication Number Publication Date
NO20031045D0 NO20031045D0 (no) 2003-03-06
NO20031045L true NO20031045L (no) 2003-04-29

Family

ID=11097081

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031045A NO20031045L (no) 2000-09-07 2003-03-06 Ny polymorf form av 17-<beta>-(N-tert.butylkarbamoyl)-4-aza-5- <alfa>-ANDROST-1-en-3-on og en fremgangsmåte for fremstilling av samme

Country Status (12)

Country Link
EP (1) EP1322663A1 (no)
JP (1) JP2004508380A (no)
AU (1) AU6991101A (no)
BR (1) BR0113732A (no)
CA (1) CA2422159A1 (no)
HU (1) HUP0300937A3 (no)
IL (1) IL154785A0 (no)
NO (1) NO20031045L (no)
NZ (1) NZ525116A (no)
PL (1) PL361014A1 (no)
WO (1) WO2002020553A1 (no)
ZA (1) ZA200302554B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2206065B1 (es) * 2002-10-31 2005-08-16 Ragactives, S.L. Procedimiento para la obtencion de la forma polimorfica i de finasterida.
US7550593B2 (en) * 2003-07-03 2009-06-23 Cipla Limited Process for the preparation of finasteride Form I
CN1294913C (zh) * 2004-12-23 2007-01-17 鲁南制药集团股份有限公司 含有非那雄胺与环糊精或其衍生物的药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225100A (en) * 1987-06-29 1991-09-25 Merck & Co Inc Reaction of steroids (including 4-azasteroids) with a silylating agent in the presence of a quinone to introduce a delta' double bond and silylated intermediates
US5237061A (en) * 1988-10-31 1993-08-17 Merck & Co., Inc. Methods of synthesizing benign prostatic hypertropic agents and their intermediates
US5021575A (en) * 1989-11-13 1991-06-04 Merck & Co., Inc. Method for introducing a 1,2 double bond into azasteroids
US5091534A (en) * 1990-08-27 1992-02-25 Merck & Co., Inc. Trialkylsilyl trifluoromethanesulfonate mediated α-methylenic carbon functionalization of 4-AZA-5α-androstan-3-one steroids
US5468860A (en) * 1992-11-19 1995-11-21 Merck & Co., Inc. New finasteride processes

Also Published As

Publication number Publication date
AU6991101A (en) 2002-03-22
BR0113732A (pt) 2003-07-29
NZ525116A (en) 2004-11-26
PL361014A1 (en) 2004-09-20
EP1322663A1 (en) 2003-07-02
CA2422159A1 (en) 2002-03-14
WO2002020553A1 (en) 2002-03-14
JP2004508380A (ja) 2004-03-18
IL154785A0 (en) 2003-10-31
HUP0300937A2 (en) 2007-02-28
ZA200302554B (en) 2004-02-19
HUP0300937A3 (en) 2007-10-29
NO20031045D0 (no) 2003-03-06

Similar Documents

Publication Publication Date Title
NO20015156D0 (no) 5-pyridyl-1,3-Azol forbindelser, fremgangsmåte for produksjon av de samme og deres anvendelse
DE60000551D1 (de) Gelbe Aufzeichnungsflüssigkeit, Herstellungsverfahren und Verwendung
EP1233780A4 (en) IDENTIFICATION OF THE SORTASE GENE
DK1036794T3 (da) 2-Aryl-8-oxodihydropurinderivater, fremgangsmåde til fremstilling af samme, medicinske præparater indeholdende samme og mellemprodukter deraf
DK1157023T3 (da) C-21-modificerede epothiloner
NO20022895L (no) Fremgangsmåter for fremstilling av karotenoider og for fremstilling av fôrmaterialer
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
DK1144386T3 (da) Polymorf form af telmisartan, fremgangsmåde til fremstilling deraf og anvendelse deraf til fremstilling af et lægemiddel
IS5715A (is) Aðferð til smíði á 4-karboxýamínó-2-setnu-1,2,3,4-tetrahýdrókínólíni
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO20012963L (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO20031319D0 (no) Fremgangsmåte for fremstilling av N-(substituert fenyl)-3- alkyl-, aryl- ogheteroaryl-sulfonyl-2-hydroksy-2-alkyl- oghalogenalkylpropanamidforbindelser
DK1138677T3 (da) Fremgangsmåde til fremstilling af 11-amino-3-chlor-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]-thiazepin og anvendelse til syntese af tianeptin
DK1399424T3 (da) Fremgangsmåde til fremstilling af 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid og 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamid
NO20013735L (no) Fremgangsmåte til fremstilling av di-iso-butaner, di-iso- butener og di-n-butener fra feltbutaner
NO20001909L (no) FremgangsmÕte og anlegg for fremstilling av 1,2-dikloretan
NO20025069L (no) Ny stabil krystall av tiazolidindionderivat og fremgangsmÕte for fremstilling av det samme
NO20030515D0 (no) Fremgangsmåte for fremstilling av dinapsolin
NO20031045L (no) Ny polymorf form av 17-&lt;beta&gt;-(N-tert.butylkarbamoyl)-4-aza-5- &lt;alfa&gt;-ANDROST-1-en-3-on og en fremgangsmåte for fremstilling av samme
NO20000965L (no) FremgangsmÕte for fremstilling av veksthormon-utskillende forbindelser
DK1341758T3 (da) Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser
ATE274683T1 (de) Pyrometallurgisches reaktorkühlelement und dessen herstellung
NO20020308D0 (no) Fremgangsmåte for fremstilling av epothiolon B og derivater, såvel som mellomprodukter for fremgangsmåten
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application